The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, disruption, and regulation of disease-associated genes.

Cancer cells have ways to hide from the immune system, but there are some unique features on these dangerous cells that ...

For the first time, a research team at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) has succeeded in ...

Sidra Medicine launches Casgevy in Qatar, the first CRISPR gene therapy for sickle cell and thalassemia, offering a potential ...

Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of ...

DOHA: Sidra Medicine, a member of Qatar Foundation, announced that it has been qualified by Vertex Pharmaceuticals as one of ...

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...